TABLE 3

Demographics of skin donors that participated in the study

Out of 16 donors in total, 87.5% were female and 12.5% were male. See Fig. 3 and Table 6 for the measured phase II metabolic activities.

Donor Code	Gender	Ethnicity	Age	Skin Anatomic Region	Smoking	Alcohol	Substrates Tested
8	Female	Caucasian	35	Abdomen	Daily	Never	4-Methylumbelliferone, 17β-estradiol, indomethacin, minoxidil
11	Female	Caucasian	59	Arm	Not known	Not known	4-Methylumbelliferone, 17β-estradiol, indomethacin, minoxidil
16	Female	Caucasian	46	Breast	Never	Occasionally	4-Methylumbelliferone, 17β-estradiol, indomethacin, diclofenac, triclosan, minoxidil
17	Female	Caucasian	43	Thigh	Daily	1–2 days/week	4-Methylumbelliferone, diclofenac, triclosan, minoxidil
18	Male	Caucasian	66	Eyelids	Former	Occasionally	4-Methylumbelliferone, diclofenac, triclosan
22	Female	Caucasian	72	Abdomen	Never	Daily	4-Methylumbelliferone, minoxidil, p-toluidine, isoniazid, procainamide, 4-nitrocatechol, 2,3-dihydroxynaphthalene
23	Female	Caucasian	59	Inguinal	Daily	Occasionally	4-Methylumbelliferone, minoxidil, p-toluidine, isoniazid, procainamide
24	Female	Caucasian	40	Abdomen	Never	Never	4-Methylumbelliferone, minoxidil, p-toluidine, isoniazid, procainamide
25	Female	Caucasian	72	Abdomen	Never	Occasionally	4-Methylumbelliferone
29	Female	Not known	57	Breast	Never	Never	4-Methylumbelliferone, 4-nitrocatechol, 2,3-dihydroxynaphthalene
30	Male	Caucasian	45	Abdomen	Daily	Occasionally	4-Methylumbelliferone, 4-nitrocatechol, 2,3-dihydroxynaphthalene
31	Female	Caucasian	59	Abdomen	Never	Daily	4-Methylumbelliferone, minoxidil, p-toluidine, 2,3-dihydroxynaphthalene
32	Female	Caucasian	54	Abdomen	Never	Occasionally	4-Methylumbelliferone, minoxidil, p-toluidine, 2,3-dihydroxynaphthalene
36	Female	Caucasian	73	Breast	Never	Occasionally	1-Chloro-2,4-dinitrobenzene
37	Female	Caucasian	63	Inguinal	Never	Occasionally	1-Chloro-2,4-dinitrobenzene
38	Female	Not known	58	Abdomen	Never	Never	1-Chloro-2,4-dinitrobenzene